Best Abstract Award

2026 PharmSci 360 Best Abstract Award Winners

See these and all the posters at PharmSci 360 in October

• A De Novo In Silico Framework for Predicting Viscosity in Self-Assembled Lipid Nanoparticulate Drug Delivery Systems Using the Einstein-Helfand Formalism, Ryan Varghese Mathew, Saint Joseph's University
• A Quantitative Analysis Correlating Prefilled Syringe and Autoinjector Dynamics with Subvisible Particle Generation in Biologic Formulations, Zhaoxi Zheng, Merck & Co., Inc.
• AEP Inhibition Enhances Autophagy in Frontotemporal Dementia, Joyal Xavier, Auburn University
• AI-Driven Gaussian Process Optimization Enables Scalable and Stable Production of NK-Exosomes for Immunotherapeutic Applications in a Syngeneic Model, Aakash Nathani, Florida A&M University
• Camexo-LNP and STAT-3 Engineered PD-L1 Exosomes: A Proprietary Dual Biomimetic Platform for Pediatric Brain Cancer Therapy, Sandeep Padakanti, Florida A&M University
• Chemopreventive Potential of Semaglutide Against Colonic Polyp Growth in an Inflammation-Accelerated Pirc Rat Model, Vesna Tumbas Saponjac, University of Houston
• Circumvention of Acquired Resistance to the Anticancer Agent Etoposide in Human Leukemia K562 Cells: Role of the Cleavage and Polyadenylation Factor PCF11, Xinyu Zhao, Ohio State University
• Comparative Adsorption Kinetics of Four Commercially Available In-Home Disposal Systems Against Immediate-Release Opioid Tablets, Konstantina (Kacey) Vavaroutsos, University of Maryland Baltimore
• Development and Characterization of a Novel Co-culture Model of Primary Cervical Epithelial Cells and Fibroblast Cells for In Vitro Permeability Studies, Riyazuddin Mohammed, University of Pittsburgh
• Development and Validation of Computational Methods to Quantify Regional Doses of Nasal Spray Drug Delivery Using Lagrangian Wall‑Film Modeling, Shamudra Dey, Medical College of Wisconsin
• Discovery of Novel Brain-Permeable Radiosensitizers Targeting PIKfyve to Overcome Glioblastoma Radioresistance, Joyeeta Khan, University of Arkansas for Medical Sciences
• Discovery of TPH104 as a Novel Thieno[2,3-d]pyrimidine-Hydrazinylidene Lead for Potent and Selective Non-Apoptotic Cell Death Induction in Triple-Negative Breast Cancer, Ahmed Ghareeb, University of Arkansas for Medical Sciences
• Enhanced Nuclear Delivery and Combination Strategies Targeting Chromosomal DNA for Cancer Therapy, Sai Pallavi Pradeep, University of Connecticut
• Ferroptosis Inhibition Drives Multi-System Therapeutic Strategy in Fuchs Endothelial Corneal Dystrophy: Insights from High-Throughput Screening of Repurposed Compounds, Apurva Dusane, University of Iowa
• In Silico-Guided Microfluidic Platform for Predictive Dissolution Testing and Surface Engineering of Nanomedicines, Sandeep Padakanti, Florida A&M University
• In Vitro Release Method Development to Understand Subcutaneous Absorption of Monoclonal Antibodies, Pawan Kumar Pandey, University of Connecticut
• Ionizable Lipid Composition Reveals Post-Endosomal mRNA Dissociation as a Key Barrier in LNP Delivery, Urmila Kafle, University of Houston
• Low‑Immunogenic, MMP‑Responsive Mitochondria‑Targeting Nanoparticles for Enhanced Tumor Drug Delivery, Nishat Ara, Texas A&M University
• Mapping the ASD Tablet Design Space: Linking Formulation Variables to Disintegration and Dissolution, Pradnya Bapat, Eli Lilly and Company
• Multiplex Cytokine and NK-Associated Secretome Profiling Demonstrates Immune Reprogramming by miR-34a-Loaded Lyophilized NK Exosomes in Lung Cancer, Aakash Nathani, Florida A&M University
• Multiplex-Guided Anti-PD-L1 Exosomes Reprogram Syngeneic Breast Tumors and Block Lung Metastasis, Mounika Aare, Florida A &M University
• Nitrosamine Risk, Quality Attributes, and Patient In‑Use Stability of Four FDA‑Approved Varenicline Tartrate Products, Mariame Ali, Texas A&M University
• Polydimethylsiloxane Curing Chemistry as a Design Variable Governing Structure-Performance Relationships in Levonorgestrel Intrauterine Systems, Ashwin Arun Abhang, University of Connecticut
• Precise Chromosomal DNA Targeting of Master Regulator VEGFA Using Engineered Nucleic Acids for Cancer Treatment, Angana De, University of Connecticut
• Precision Assembly of Personalized Multi-Unit Oral Dosage Forms Using API-Concentrate Solid Subunits, Erik Sonntag, University of Chemistry & TechnologyPrague
• Selective LXR-β Activation via Novel Drug Promotes Remyelination and Neuronal Repair in Models of Frontotemporal Dementia, Sampada Tamhankar, Auburn University
• Sphingomyelin Rich Nanoliposomes of Lipophilic Gemcitabine: Exploring a Potential Modality for Treatment of Naïve and Drug-Resistant Brain Cancer, Bhoomi Dholariya, St. John's University
• Stability Signatures across Trastuzumab, Radioimmunoconjugate, and Antibody-Drug Conjugate Modalities, Siddhanth Hejmady, University of Iowa
• Supersaturated Lipid-Based Formulations of Olaparib: Linking Structure-Function Relationships to Oral Absorption and IVIVC, Kajal Guleria, National Institute of Pharmaceutical Education and Research
• Systemic Control, CNS Escape: Regimen-Specific Differences in Brain HIV Suppression Revealed in a Humanized Microglial Mouse Model, Elizabeth Etafo, University of Nebraska Medical Center
• Ternary Phase Diagrams as Predictive Tools for Amorphous Solid Dispersions, Simisola Oloye, Purdue University
• Ultrafast Bio-Adhesive Alginate Hydrogel Sealant for Intraoperative and Prolonged Gastrointestinal Hemostasis, Iram Maqsood, University of Maryland Baltimore
• Understanding the Role of Excipient-API Interactions in Depot Formation and In Vivo Performance of Long-Acting Injectable Suspensions, Saurabh Bhorkade, University of Connecticut
• Using Scientific Machine Learning to Analyze Sedimentation Velocity Analytical Ultracentrifugation Data, Andrew Basalla, University of Texas at Austin